Experiment set22IT058 for Pseudomonas fluorescens SBW25-INTG
4-hydroxyphenylacetic acid 2 mM carbon source
Group: carbon sourceMedia: MME_noNitrogen_noCarbon + 4-hydroxyphenylacetic acid (2 mM) + Ammonium chloride (10 mM), pH=7
Culturing: PseudoSBW25_INTG_ML3, 24-well transparent microplate; Multitron, Aerobic, at 30 (C), shaken=700 rpm
By: Joshua Elmore on 8-Mar-22
Media components: 9.1 mM Potassium phosphate dibasic trihydrate, 20 mM 3-(N-morpholino)propanesulfonic acid, 4.3 mM Sodium Chloride, 0.41 mM Magnesium Sulfate Heptahydrate, 0.07 mM Calcium chloride dihydrate, MME Trace Minerals (0.5 mg/L EDTA tetrasodium tetrahydrate salt, 2 mg/L Ferric chloride, 0.05 mg/L Boric Acid, 0.05 mg/L Zinc chloride, 0.03 mg/L copper (II) chloride dihydrate, 0.05 mg/L Manganese (II) chloride tetrahydrate, 0.05 mg/L Diammonium molybdate, 0.05 mg/L Cobalt chloride hexahydrate, 0.05 mg/L Nickel (II) chloride hexahydrate)
Specific Phenotypes
For 9 genes in this experiment
For carbon source 4-hydroxyphenylacetic acid in Pseudomonas fluorescens SBW25-INTG
For carbon source 4-hydroxyphenylacetic acid across organisms
SEED Subsystems
Metabolic Maps
Color code by fitness: see overview map or list of maps.
Maps containing gene(s) with specific phenotypes:
- Tyrosine metabolism
- Glutamate metabolism
- Lysine biosynthesis
- Butanoate metabolism
- Riboflavin metabolism
- Urea cycle and metabolism of amino groups
- Geraniol degradation
- Arginine and proline metabolism
- Tryptophan metabolism
- alpha-Linolenic acid metabolism
- 1- and 2-Methylnaphthalene degradation
- Naphthalene and anthracene degradation
- Limonene and pinene degradation
MetaCyc Pathways
Pathways that contain genes with specific phenotypes:
| Pathway | #Steps | #Present | #Specific |
|---|---|---|---|
| 4-aminobutanoate degradation I | 2 | 2 | 1 |
| 4-aminobutanoate degradation III | 2 | 2 | 1 |
| superpathway of 4-aminobutanoate degradation | 3 | 3 | 1 |
| 4-aminobutanoate degradation IV | 3 | 1 | 1 |
| N-methylpyrrolidone degradation | 3 | 1 | 1 |
| 4-hydroxyphenylacetate degradation | 8 | 6 | 2 |
| GABA shunt II | 4 | 3 | 1 |
| GABA shunt I | 4 | 2 | 1 |
| flavin biosynthesis I (bacteria and plants) | 9 | 8 | 2 |
| flavin biosynthesis III (fungi) | 9 | 7 | 2 |
| L-lysine degradation IV | 5 | 5 | 1 |
| 6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia) | 5 | 3 | 1 |
| L-lysine degradation X | 6 | 5 | 1 |
| L-lysine degradation III | 6 | 2 | 1 |
| L-lysine degradation I | 7 | 4 | 1 |
| toxoflavin biosynthesis | 7 | 3 | 1 |
| L-lysine biosynthesis I | 9 | 9 | 1 |
| flavin biosynthesis II (archaea) | 10 | 5 | 1 |
| superpathway of L-arginine, putrescine, and 4-aminobutanoate degradation | 11 | 7 | 1 |
| superpathway of L-arginine and L-ornithine degradation | 13 | 9 | 1 |
| superpathway of L-lysine, L-threonine and L-methionine biosynthesis I | 18 | 16 | 1 |
| aspartate superpathway | 25 | 22 | 1 |
| superpathway of L-lysine degradation | 43 | 17 | 1 |